What does CUSIP 90400D108 represent in this 13F holders report?

CUSIP 90400D108 is the security identifier for RARE - Ultragenyx Pharmaceutical Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held RARE - Ultragenyx Pharmaceutical Inc. - Common Stock in Q2 2020?

185 institutional investors reported RARE - Ultragenyx Pharmaceutical Inc. - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

Ultragenyx Pharmaceutical Inc. - Common Stock (RARE)

CUSIP: 90400D108

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock
Shares outstanding: 98,367,418
Total 13F shares: 63,208,158
Share change: +3,035,937
Total reported value: $4,944,359,312
Put/Call ratio: 60%
Price per share: $78.22
Number of holders: 185
Value change: +$242,670,060
Number of buys: 97
Number of sells: 77

Quarterly Holders Quick Answers

What is CUSIP 90400D108?
CUSIP 90400D108 identifies RARE - Ultragenyx Pharmaceutical Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 90400D108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RARE - Ultragenyx Pharmaceutical Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital Research Global Investors	13F	Company	6.7%	6,573,960	$292,081,000	—	31 Mar 2020	13F
Capital International Investors	13F	Company	6.2%	6,132,194	$272,453,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	5.1%	4,968,839	$220,765,000	—	31 Mar 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	4.8%	4,708,822	$209,213,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	4.6%	4,563,531	$202,757,000	—	31 Mar 2020	13F
FEDERATED HERMES, INC.	13F	Company	4.1%	4,016,760	$178,465,000	—	31 Mar 2020	13F
Capital World Investors	13F	Company	3.3%	3,237,381	$143,837,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	2.3%	2,229,351	$99,050,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	1.8%	1,775,710	$78,895,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	1.7%	1,627,108	$72,293,000	—	31 Mar 2020	13F
MACQUARIE GROUP LTD	13F	Company	1.6%	1,622,502	$72,087,000	—	31 Mar 2020	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	1.6%	1,620,533	$72,000,000	—	31 Mar 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.4%	1,413,041	$62,781,000	—	31 Mar 2020	13F
Clearbridge Investments, LLC	13F	Company	1.2%	1,229,310	$54,618,000	—	31 Mar 2020	13F
FIRST TRUST ADVISORS LP	13F	Company	0.96%	946,504	$42,053,000	—	31 Mar 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.85%	836,557	$37,168,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.83%	816,975	$36,298,000	—	31 Mar 2020	13F
Rock Springs Capital Management LP	13F	Company	0.76%	747,800	$33,225,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.73%	721,103	$32,039,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.72%	704,416	$31,297,000	—	31 Mar 2020	13F
NORGES BANK	13F	Company	0.52%	512,564	$22,773,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.48%	474,858	$21,098,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.46%	455,522	$20,238,000	—	31 Mar 2020	13F
Capital International, Inc./CA/	13F	Company	0.46%	450,495	$20,015,000	—	31 Mar 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.42%	408,518	$18,149,000	—	31 Mar 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.41%	398,474	$17,705,000	—	31 Mar 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.39%	382,473	$16,993,000	—	31 Mar 2020	13F
EcoR1 Capital, LLC	13F	Company	0.38%	371,208	$16,493,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.35%	343,099	$15,244,000	—	31 Mar 2020	13F
First Light Asset Management, LLC	13F	Company	0.35%	342,603	$15,222,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.34%	331,091	$14,710,000	—	31 Mar 2020	13F
AXA S.A.	13F	Company	0.3%	296,617	$13,179,000	—	31 Mar 2020	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.27%	269,883	$11,991,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.25%	241,011	$10,708,000	—	31 Mar 2020	13F
Hudson Bay Capital Management LP	13F	Company	0.24%	233,706	$10,384,000	—	31 Mar 2020	13F
PINNACLE ASSOCIATES LTD	13F	Company	0.18%	178,771	$7,943,000	—	31 Mar 2020	13F
CREDIT SUISSE AG/	13F	Company	0.16%	160,238	$7,120,000	—	31 Mar 2020	13F
BARCLAYS PLC	13F	Company	0.15%	151,772	$6,742,000	—	31 Mar 2020	13F
Gamma As Sector	13F	Individual	0.15%	145,072	$6,446,000	—	31 Mar 2020	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	0.14%	141,870	$6,303,000	—	31 Mar 2020	13F
UBS Group AG	13F	Company	0.13%	130,830	$5,813,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.12%	121,613	$5,403,000	—	31 Mar 2020	13F
S.c.a. Candriam	13F	Individual	0.12%	121,500	$5,073,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.11%	111,710	$4,963,000	—	31 Mar 2020	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.11%	110,529	$4,911,000	—	31 Mar 2020	13F
Swiss National Bank	13F	Company	0.11%	106,452	$4,730,000	—	31 Mar 2020	13F
Tekla Capital Management LLC	13F	Company	0.1%	97,480	$4,331,000	—	31 Mar 2020	13F
Erste Asset Management GmbH	13F	Company	0.1%	95,310	$4,229,639	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.09%	90,789	$4,034,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.09%	85,508	$3,799,000	—	31 Mar 2020	13F

Institutional Holders of Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) as of Q2 2020

As of 30 Jun 2020, Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) was held by 185 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 63,208,158 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, Capital Research Global Investors, Capital International Investors, VANGUARD GROUP INC, BlackRock Inc., FEDERATED HERMES, INC., Capital World Investors, STATE STREET CORP, ALKEON CAPITAL MANAGEMENT LLC, and Clearbridge Investments, LLC. This page lists 185 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

166

Q2 2020 holders

185

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.